1. none of the completion dates or time lines matt
Post# of 148166
I 100% disagree. If Leronlimab is approved for COVID19, the SP will skyrocket regardless of how much supply is available at the time or when more is arriving. The supply of remdesevir was not great at the time the EUA was given and GILD has since worked on the supply issue.